TY - JOUR AU - Hynes, N. E. AU - Lane, H. A. PY - 2005 DA - 2005// TI - ERBB receptors and cancer: the complexity of targeted inhibitors JO - Nat Rev Cancer VL - 5 UR - https://doi.org/10.1038/nrc1609 DO - 10.1038/nrc1609 ID - Hynes2005 ER - TY - JOUR AU - Citri, A. AU - Yarden, Y. PY - 2006 DA - 2006// TI - EGF-ERBB signalling: towards the systems level JO - Nat Rev Mol Cell Biol VL - 7 UR - https://doi.org/10.1038/nrm1962 DO - 10.1038/nrm1962 ID - Citri2006 ER - TY - JOUR AU - Jones, R. B. AU - Gordus, A. AU - Krall, J. A. AU - MacBeath, G. PY - 2006 DA - 2006// TI - A quantitative protein interaction network for the ErbB receptors using protein microarrays JO - Nature VL - 439 UR - https://doi.org/10.1038/nature04177 DO - 10.1038/nature04177 ID - Jones2006 ER - TY - JOUR AU - Yarden, Y. AU - Sliwkowski, M. X. PY - 2001 DA - 2001// TI - Untangling the ErbB signalling network JO - Nat Rev Mol Cell Biol VL - 2 UR - https://doi.org/10.1038/35052073 DO - 10.1038/35052073 ID - Yarden2001 ER - TY - JOUR AU - Shepherd, F. A. PY - 2005 DA - 2005// TI - Erlotinib in previously treated non-small-cell lung cancer JO - N Engl J Med VL - 353 UR - https://doi.org/10.1056/NEJMoa050753 DO - 10.1056/NEJMoa050753 ID - Shepherd2005 ER - TY - JOUR AU - Bollag, G. PY - 2012 DA - 2012// TI - Vemurafenib: the first drug approved for BRAF-mutant cancer JO - Nat Rev Drug Discov VL - 11 UR - https://doi.org/10.1038/nrd3847 DO - 10.1038/nrd3847 ID - Bollag2012 ER - TY - JOUR AU - Karapetis, C. S. PY - 2008 DA - 2008// TI - K-ras mutations and benefit from cetuximab in advanced colorectal cancer JO - N Engl J Med VL - 359 UR - https://doi.org/10.1056/NEJMoa0804385 DO - 10.1056/NEJMoa0804385 ID - Karapetis2008 ER - TY - JOUR AU - Prior, I. A. AU - Lewis, P. D. AU - Mattos, C. PY - 2012 DA - 2012// TI - A comprehensive survey of Ras mutations in cancer JO - Cancer Res VL - 72 UR - https://doi.org/10.1158/0008-5472.CAN-11-2612 DO - 10.1158/0008-5472.CAN-11-2612 ID - Prior2012 ER - TY - JOUR AU - Stephen, A. G. AU - Esposito, D. AU - Bagni, R. K. AU - McCormick, F. PY - 2014 DA - 2014// TI - Dragging ras back in the ring JO - Cancer Cell VL - 25 UR - https://doi.org/10.1016/j.ccr.2014.02.017 DO - 10.1016/j.ccr.2014.02.017 ID - Stephen2014 ER - TY - JOUR AU - Vigil, D. AU - Cherfils, J. AU - Rossman, K. L. AU - Der, C. J. PY - 2010 DA - 2010// TI - Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy? JO - Nat Rev Cancer VL - 10 UR - https://doi.org/10.1038/nrc2960 DO - 10.1038/nrc2960 ID - Vigil2010 ER - TY - JOUR AU - Sherekar, M. PY - 2020 DA - 2020// TI - Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer JO - J Biol Chem VL - 295 UR - https://doi.org/10.1074/jbc.RA119.010934 DO - 10.1074/jbc.RA119.010934 ID - Sherekar2020 ER - TY - JOUR AU - Scheffzek, K. PY - 1997 DA - 1997// TI - The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants JO - Science VL - 277 UR - https://doi.org/10.1126/science.277.5324.333 DO - 10.1126/science.277.5324.333 ID - Scheffzek1997 ER - TY - JOUR AU - Ahmadian, M. R. AU - Mittal, R. AU - Hall, A. AU - Wittinghofer, A. PY - 1997 DA - 1997// TI - Aluminum fluoride associates with the small guanine nucleotide binding proteins JO - FEBS Lett VL - 408 UR - https://doi.org/10.1016/S0014-5793(97)00422-5 DO - 10.1016/S0014-5793(97)00422-5 ID - Ahmadian1997 ER - TY - JOUR AU - Hunter, J. C. PY - 2015 DA - 2015// TI - Biochemical and structural analysis of common Cancer-associated KRAS mutations JO - Mol Cancer Res VL - 13 UR - https://doi.org/10.1158/1541-7786.MCR-15-0203 DO - 10.1158/1541-7786.MCR-15-0203 ID - Hunter2015 ER - TY - JOUR AU - Roock, W. PY - 2010 DA - 2010// TI - Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab JO - JAMA VL - 304 UR - https://doi.org/10.1001/jama.2010.1535 DO - 10.1001/jama.2010.1535 ID - Roock2010 ER - TY - JOUR AU - Morelli, M. P. AU - Kopetz, S. PY - 2012 DA - 2012// TI - Hurdles and complexities of codon 13 KRAS mutations JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2012.43.6535 DO - 10.1200/JCO.2012.43.6535 ID - Morelli2012 ER - TY - STD TI - McFall T, Diedrich JK, Mengistu M, Littlechild SL, Paskvan KV, Sisk-Hackworth L, Moresco JJ, Shaw AS, Stites EC. A systems mechanism for KRAS mutant allele–specific responses to targeted therapy. Sci Signal. 2019;12:eaaw8288. ID - ref17 ER - TY - JOUR AU - Rabara, D. PY - 2019 DA - 2019// TI - KRAS G13D sensitivity to neurofibromin-mediated GTP hydrolysis JO - Proc Natl Acad Sci U S A VL - 116 UR - https://doi.org/10.1073/pnas.1908353116 DO - 10.1073/pnas.1908353116 ID - Rabara2019 ER - TY - JOUR AU - Stites, E. C. AU - Trampont, P. C. AU - Ma, Z. AU - Ravichandran, K. S. PY - 2007 DA - 2007// TI - Network analysis of oncogenic Ras activation in cancer JO - Science VL - 318 UR - https://doi.org/10.1126/science.1144642 DO - 10.1126/science.1144642 ID - Stites2007 ER - TY - JOUR AU - Scheffzek, K. PY - 1998 DA - 1998// TI - Structural analysis of the GAP-related domain from neurofibromin and its implications JO - EMBO J VL - 17 UR - https://doi.org/10.1093/emboj/17.15.4313 DO - 10.1093/emboj/17.15.4313 ID - Scheffzek1998 ER - TY - JOUR AU - McFall, T. AU - Stites, E. C. PY - 2020 DA - 2020// TI - A mechanism for the response of KRAS(G13D) expressing colorectal cancers to EGFR inhibitors JO - Mol Cell Oncol VL - 7 UR - https://doi.org/10.1080/23723556.2019.1701914 DO - 10.1080/23723556.2019.1701914 ID - McFall2020 ER - TY - STD TI - E. C. Stites, P. C. Trampont, L. B. Haney, S. F. Walk, K. S. Ravichandran, Cooperation between Noncanonical Ras Network Mutations Cell Rep https://doi.org/10.1016/j.celrep.2014.12.035 (2015). ID - ref22 ER - TY - JOUR AU - Brune, M. AU - Hunter, J. L. AU - Corrie, J. E. AU - Webb, M. R. PY - 1994 DA - 1994// TI - Direct, real-time measurement of rapid inorganic phosphate release using a novel fluorescent probe and its application to actomyosin subfragment 1 ATPase JO - Biochemistry VL - 33 UR - https://doi.org/10.1021/bi00193a013 DO - 10.1021/bi00193a013 ID - Brune1994 ER -